Troluce Capital Advisors LLC Roivant Sciences Ltd. Transaction History
Troluce Capital Advisors LLC
- $826 Million
- Q2 2024
A detailed history of Troluce Capital Advisors LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Troluce Capital Advisors LLC holds 2,950,000 shares of ROIV stock, worth $34.3 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
2,950,000Holding current value
$34.3 Million% of portfolio
3.78%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
321Shares Held
497MCall Options Held
1.29MPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$831 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$805 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$777 Million72.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$485 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$412 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.2B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...